GO:0033146 regulation of intracellular estrogen receptor signaling pathway: Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0033146 describes any process that modulates the frequency, rate or extent of an intracellular estrogen receptor signaling pathway.
• Estrogen receptors (ESR1/ERα and ESR2/ERβ) mediate both nuclear genomic and membrane-initiated nongenomic signaling that converge on target genes.
• Regulation occurs at multiple levels, including ligand availability, receptor phosphorylation, coregulator recruitment, and crosstalk with growth factor pathways.
• Dysregulation of intracellular estrogen receptor signaling is implicated in breast cancer, endometrial cancer, cervical cancer, and metabolic and skeletal muscle disorders.
• Key experimental approaches include CRISPR knockout, point mutation, knock-in, overexpression, RNA-seq, proteomics, and imaging.
• Understanding this regulatory process is essential for developing targeted therapies and for interpreting endocrine resistance mechanisms.
Description
The Gene Ontology term GO:0033146, regulation of intracellular estrogen receptor signaling pathway, refers to any process that modulates the frequency, rate or extent of an intracellular estrogen receptor signaling pathway. Estrogen receptors are ligand-activated transcription factors that also participate in rapid, membrane-initiated signaling cascades, and their activity is tightly controlled to maintain normal physiology. This regulatory process is fundamental to how cells interpret estrogenic signals and translate them into changes in gene expression, proliferation, differentiation, and survival. Researchers study GO:0033146 because its disruption contributes to a wide range of pathologies, including hormone-dependent cancers, metabolic dysfunction, and neurological disorders. The term encompasses both genomic and nongenomic actions of estrogen receptors, reflecting the convergence of multiple signaling inputs on receptor function. Understanding the regulatory mechanisms that govern intracellular estrogen receptor signaling is therefore critical for both basic biology and therapeutic development.
regulation of intracellular estrogen receptor signaling pathway At A Glance
| GO ID | GO:0033146 |
|---|---|
| GO term | regulation of intracellular estrogen receptor signaling pathway |
| Ontology | biological_process |
| Synonym | regulation of estrogen receptor signaling pathway; regulation of estrogen receptor signalling pathway |
| Major function | Modulates the frequency, rate or extent of intracellular estrogen receptor signaling |
| Related receptors | ESR1 (ERα), ESR2 (ERβ), GPER1 (GPR30) |
| Signaling modes | Genomic (nuclear) and nongenomic (membrane-initiated) |
| Key regulatory inputs | Ligand availability, phosphorylation, coregulators, growth factor crosstalk |
What Is GO:0033146?
GO:0033146 is defined as any process that modulates the frequency, rate or extent of the activity of an intracellular estrogen receptor signaling pathway. In other words, it includes all molecular events that adjust how estrogen receptors transmit signals inside the cell, whether by altering receptor abundance, post-translational modifications, interactions with coregulators, or crosstalk with other signaling pathways.
Why Is regulation of intracellular estrogen receptor signaling pathway Important in Cell Biology?
Regulation of intracellular estrogen receptor signaling is essential for normal development, reproduction, and tissue homeostasis, and its dysregulation is a hallmark of hormone-dependent cancers and other diseases. Because estrogen receptors influence diverse cellular processes, understanding how their signaling is controlled provides insight into disease mechanisms and identifies potential therapeutic targets.
• Controls gene expression programs involved in cell proliferation and differentiation.
• Modulates rapid membrane-initiated signaling that affects neuronal and metabolic functions.
• Dysregulation is linked to breast, endometrial, and cervical cancers.
• Plays a role in skeletal muscle maintenance and function.
• Influences reward circuitry and motivated behaviors in the female brain.
• Serves as a paradigm for understanding crosstalk between nuclear and membrane signaling.
• Provides targets for endocrine therapy and resistance management.
• Involves coregulator proteins that are frequently mutated in cancer.
• Affects bone, cardiovascular, and immune systems.
• Is a focus for CRISPR-based functional genomics and drug discovery.
What Happens During regulation of intracellular estrogen receptor signaling pathway?
Ligand-dependent activation and receptor dimerization
In simple terms: Estrogen binds to the receptor, causing it to pair up and become active.
Estrogen binding to ESR1 or ESR2 induces conformational changes that promote receptor dimerization and translocation to the nucleus, where the receptors bind estrogen response elements (EREs) in target genes. This genomic pathway is the classical mechanism of estrogen receptor signaling and is subject to regulation by ligand availability and receptor post-translational modifications.
Membrane-initiated nongenomic signaling
In simple terms: Estrogen can also trigger fast signals at the cell membrane without entering the nucleus.
A subpopulation of estrogen receptors localized at the plasma membrane, along with GPER1, activates rapid signaling cascades including MAPK/ERK, PI3K/AKT, and calcium flux. These nongenomic actions can modulate gene transcription indirectly and are integrated with nuclear signaling to shape cellular responses.
Coregulator recruitment and chromatin remodeling
In simple terms: Helper proteins join the receptor on DNA to turn genes on or off.
Once bound to DNA, estrogen receptors recruit coactivators or corepressors that modify chromatin and facilitate or repress transcription. The balance of these coregulators is a key point of regulation and can be altered in disease states.
Crosstalk with growth factor and other signaling pathways
In simple terms: Other signals can talk to the estrogen receptor and change its activity.
Growth factor signaling pathways, such as EGFR and IGF-1R, can phosphorylate estrogen receptors and their coregulators, enhancing ligand-independent activation. This crosstalk is a major mechanism of endocrine resistance in breast cancer and represents a regulatory node for therapeutic intervention.
Feedback regulation and receptor turnover
In simple terms: The cell can adjust how much receptor is available and how long it lasts.
Estrogen receptor levels are regulated by transcriptional feedback, ubiquitination, and proteasomal degradation. These processes ensure appropriate signal duration and are critical for maintaining cellular responsiveness to estrogen.
Key Genes Involved in GO:0033146 regulation of intracellular estrogen receptor signaling pathway
The following genes and proteins are central to the regulation of intracellular estrogen receptor signaling, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ESR1 | Estrogen receptor alpha; mediates genomic and nongenomic estrogen signaling | Primary target in breast cancer and endocrine therapy |
| ESR2 | Estrogen receptor beta; modulates estrogen signaling with distinct tissue-specific effects | Implicated in cancer and neuronal function |
| GPER1 | G protein-coupled estrogen receptor; mediates rapid membrane-initiated signaling | Target in cervical cancer and other malignancies |
| NCOA1 | Nuclear receptor coactivator 1; enhances estrogen receptor transcriptional activity | Coregulator frequently altered in cancer |
| NCOA2 | Nuclear receptor coactivator 2; coactivator for estrogen receptors | Associated with endocrine resistance |
| NCOR1 | Nuclear receptor corepressor 1; represses estrogen receptor target genes | Modulates response to endocrine therapy |
| NCOR2 | Nuclear receptor corepressor 2; corepressor with roles in estrogen signaling | Involved in breast cancer progression |
| MED1 | Mediator complex subunit 1; bridges estrogen receptors to transcription machinery | Required for estrogen-dependent gene expression |
| SP1 | Transcription factor that cooperates with estrogen receptors at GC-rich promoters | Modulates estrogen-responsive genes |
| AP1 | Transcription factor complex that interacts with estrogen receptors | Mediates nongenomic to genomic signaling convergence |
| EGFR | Growth factor receptor that crosstalks with estrogen receptor signaling | Contributes to endocrine resistance |
| IGF1R | Insulin-like growth factor 1 receptor; activates estrogen receptor via phosphorylation | Target for combination therapy |
| MAPK1 | Extracellular signal-regulated kinase 2; downstream of membrane estrogen receptor signaling | Key node in nongenomic signaling |
| AKT1 | Protein kinase B; mediates survival signals from estrogen receptors | Implicated in cancer cell survival |
| PIK3CA | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha; activates AKT | Frequently mutated in hormone-dependent cancers |
| SRC | Proto-oncogene tyrosine-protein kinase Src; phosphorylates estrogen receptors | Modulates nongenomic signaling |
| MMP2 | Matrix metalloproteinase 2; releases growth factors that activate estrogen receptors | Involved in tissue remodeling and cancer |
How Is regulation of intracellular estrogen receptor signaling pathway Regulated?
The regulation of intracellular estrogen receptor signaling is itself controlled by multiple mechanisms, including ligand availability, receptor phosphorylation, ubiquitination, and interactions with coregulators and growth factor pathways. For example, phosphorylation of ESR1 by MAPK or AKT can enhance its transcriptional activity and promote ligand-independent activation. Additionally, feedback loops involving receptor degradation and corepressor recruitment ensure that signaling is appropriately terminated. These regulatory layers are critical for maintaining normal physiology and are often disrupted in disease.
regulation of intracellular estrogen receptor signaling pathway and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ESR1 | Breast cancer, endocrine resistance | CRISPR knockout or point mutation in MCF-7 cells |
| GPER1 | Cervical cancer | Knockout or overexpression in HeLa cells |
| ESR2 | Cancer, neuronal function | Knock-in reporter in neuronal cell lines |
| NCOA1 | Breast cancer | Knockout in breast cancer organoids |
| IGF1R | Endocrine resistance | Point mutation to block phosphorylation in cancer cells |
Breast cancer and endocrine resistance
Dysregulated estrogen receptor signaling is a driving force in the majority of breast cancers, and alterations in its regulation can lead to resistance to endocrine therapies such as tamoxifen and aromatase inhibitors. Mutations in ESR1 and changes in coregulator expression are common mechanisms of resistance.
Cervical cancer
GPER1-mediated signaling, a component of intracellular estrogen receptor signaling, has been implicated in cervical cancer progression, and its inhibition reduces tumor growth in preclinical models.
Metabolic and skeletal muscle disorders
Estrogen receptor signaling in skeletal muscle is important for muscle maintenance and function, and its dysregulation contributes to sarcopenia and metabolic dysfunction.
Neurological and behavioral disorders
Membrane estrogen receptor signaling in the brain influences reward circuitry and motivated behaviors, and its disruption has been linked to mood disorders and addiction.
From regulation of intracellular estrogen receptor signaling pathway-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does ESR1 mutation confer ligand-independent activity? | Point mutation knock-in in breast cancer cell lines |
| What is the role of GPER1 in cervical cancer growth? | CRISPR knockout in HeLa or SiHa cells |
| How does ESR2 modulate neuronal signaling? | Overexpression or knockout in neuronal cultures |
| What coregulators are essential for estrogen-dependent transcription? | CRISPR library screening in MCF-7 cells |
| How does phosphorylation of ESR1 affect its interactome? | Phospho-mutant knock-in followed by proteomics |
| Can targeting membrane estrogen receptor signaling alter behavior? | Conditional knockout in mouse brain |
How to Study the regulation of intracellular estrogen receptor signaling pathway Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global gene expression changes | Identify estrogen-regulated genes |
| ChIP-seq | Estrogen receptor binding sites on chromatin | Map genomic targets |
| Proteomics | Protein-protein interactions and post-translational modifications | Discover coregulators and phosphorylation events |
| Phosphoproteomics | Phosphorylation status of signaling proteins | Analyze nongenomic signaling cascades |
| Live-cell imaging | Receptor localization and dynamics | Study membrane vs nuclear signaling |
| CRISPR knockout | Loss-of-function phenotypes | Validate gene function in signaling |
| CRISPR library screening | Pooled fitness or reporter screens | Identify regulators of estrogen receptor activity |
| Reporter assays | Transcriptional activity of estrogen receptors | Measure ligand-dependent and independent activation |
Transcriptomic profiling
RNA-seq can identify global changes in gene expression upon modulation of estrogen receptor signaling, revealing downstream targets and regulatory networks.
Proteomic and phosphoproteomic analysis
Mass spectrometry-based proteomics can quantify estrogen receptor interactions and phosphorylation events that regulate its activity.
Imaging of receptor localization and dynamics
Fluorescence microscopy and live-cell imaging can visualize estrogen receptor trafficking between nucleus and membrane, and its interactions with coregulators.
CRISPR-based functional genomics
CRISPR knockout, knock-in, and library screening enable systematic dissection of genes that regulate estrogen receptor signaling and their contribution to disease phenotypes.
How CRISPR Can Be Used to Study GO:0033146 regulation of intracellular estrogen receptor signaling pathway
Knockout
CRISPR knockout of ESR1, ESR2, GPER1, or coregulator genes can abolish specific signaling arms and reveal their contribution to estrogen-dependent phenotypes.
Point Mutation
Introducing point mutations such as ESR1 Y537S or D538G via CRISPR can model clinical endocrine resistance and study ligand-independent activation.
Knock-in
Knock-in of tagged estrogen receptors (e.g., GFP or HA) allows for imaging and proteomic analysis of receptor complexes in a physiological context.
Overexpression
Overexpression of wild-type or mutant estrogen receptors or coregulators can mimic gain-of-function states observed in cancer and test therapeutic vulnerabilities.
How EDITGENE Supports regulation of intracellular estrogen receptor signaling pathway Research
Researchers studying regulation of intracellular estrogen receptor signaling pathway-related genes often need to determine whether a candidate gene is causally involved in receptor regulation or disease progression. EDITGENE provides a comprehensive suite of CRISPR-based services to enable such functional studies with high precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for regulation of intracellular estrogen receptor signaling pathway research.
Frequently Asked Questions About regulation of intracellular estrogen receptor signaling pathway
What is GO:0033146?
GO:0033146 is the Gene Ontology term for regulation of intracellular estrogen receptor signaling pathway, defined as any process that modulates the frequency, rate or extent of an intracellular estrogen receptor signaling pathway.
What genes are involved in regulation of intracellular estrogen receptor signaling pathway?
Key genes include ESR1, ESR2, GPER1, and coregulators such as NCOA1, NCOA2, NCOR1, and NCOR2.
How is intracellular estrogen receptor signaling regulated?
It is regulated by ligand availability, receptor phosphorylation, coregulator recruitment, crosstalk with growth factor pathways, and feedback degradation.
What diseases are associated with dysregulated estrogen receptor signaling?
Breast cancer, cervical cancer, metabolic disorders, and neurological conditions have been linked to dysregulated estrogen receptor signaling.
What experimental models are used to study GO:0033146?
Common models include CRISPR knockout, point mutation, knock-in, and overexpression cell lines, as well as animal models.
How can CRISPR help study estrogen receptor signaling?
CRISPR enables precise genetic modifications to dissect the roles of specific genes and mutations in estrogen receptor signaling and disease.
What is the difference between genomic and nongenomic estrogen receptor signaling?
Genomic signaling involves nuclear receptor binding to DNA and transcription, while nongenomic signaling occurs rapidly at the membrane via kinase cascades.
Which coregulators are important for estrogen receptor function?
NCOA1, NCOA2, NCOR1, NCOR2, and MED1 are among the key coregulators that modulate estrogen receptor transcriptional activity.
How does GPER1 relate to intracellular estrogen receptor signaling?
GPER1 mediates rapid membrane-initiated estrogen signaling and is considered part of the broader intracellular estrogen receptor signaling network.
What methods are used to study regulation of estrogen receptor signaling?
RNA-seq, ChIP-seq, proteomics, imaging, and CRISPR screens are commonly used to study this regulatory process.
Conclusion
GO:0033146 encompasses the complex regulatory mechanisms that control intracellular estrogen receptor signaling, integrating genomic and nongenomic pathways. Understanding these processes is crucial for elucidating normal physiology and for developing targeted therapies against hormone-dependent diseases. CRISPR-based models and multi-omics approaches continue to advance our knowledge of this critical signaling axis.
References
- 1. Ikeda K et al.. 2019. Functions of estrogen and estrogen receptor signaling on skeletal muscle.. J Steroid Biochem Mol Biol 191:105375 PMID: 31067490
- 2. Cheskis BJ et al.. 2007. Signaling by estrogens.. J Cell Physiol 213(3):610-7 PMID: 17886255
- 3. Zhang D et al.. 2006. Integration of membrane and nuclear estrogen receptor signaling.. Comp Biochem Physiol A Mol Integr Physiol 144(3):306-15 PMID: 16516516
- 4. Tonn Eisinger KR et al.. 2018. Membrane estrogen receptor signaling impacts the reward circuitry of the female brain to influence motivated behaviors.. Steroids 133:53-59 PMID: 29195840
- 5. Fu XD et al.. 2008. Extra-nuclear signaling of estrogen receptors.. IUBMB Life 60(8):502-10 PMID: 18618586
- 6. Zhu Z et al.. 2024. Regulation of cervical cancer via G15-mediated inhibition of G protein-coupled estrogen receptor.. Anticancer Drugs 35(9):817-829 PMID: 39018257
- 7. Björnström L et al.. 2005. Mechanisms of estrogen receptor signaling: convergence of genomic and nongenomic actions on target genes.. Mol Endocrinol 19(4):833-42 PMID: 15695368
- 8. Gui Z et al.. 2025. The role of estrogen receptors in intracellular estrogen signaling pathways, an overview.. J Steroid Biochem Mol Biol 245:106632 PMID: 39551163
